Thirty Madison Prescription Process: How the Intake Works, What Gets Prescribed, and Whether It's Worth It

How Thirty Madison's Intake Process Works

The intake across all four Thirty Madison brands follows the same pattern: a structured online questionnaire that collects medical history, current symptoms, medication use, and treatment goals. A licensed provider reviews the submission asynchronously, typically within 24 hours, and either approves a prescription, requests additional information, or recommends the patient see an in-person provider instead.

The Questionnaire Structure

Each sub-brand tailors its intake to the specific condition. Keeps asks about hair loss pattern, family history, and duration. Cove asks about migraine frequency, aura presence, and prior triptan use. The questions map to clinical screening criteria. For hair loss, they align with the Hamilton-Norwood classification scale, which remains the standard grading system in androgenetic alopecia research [1]. For migraine, the intake mirrors International Classification of Headache Disorders (ICHD-3) diagnostic criteria [2].

No photo upload is required for Keeps (though it is encouraged), while Facet requires photos of the skin condition. The entire questionnaire takes 5 to 10 minutes.

Provider Review and Prescribing

After submission, a licensed physician or nurse practitioner licensed in the patient's state reviews the intake. This is not an AI-generated prescription. A real clinician evaluates the responses and makes a prescribing decision. If the provider determines the patient is not a good candidate (for example, a woman of childbearing age requesting finasteride without documented contraception), the consultation ends without a prescription, and the patient is referred to in-person care.

This asynchronous model has tradeoffs. It is faster and more accessible than scheduling a dermatology appointment, where the average wait time in the U.S. Is 34.1 days according to a 2022 Merritt Hawkins survey [3]. But it removes the physical exam entirely. For conditions like androgenetic alopecia, where the diagnosis is primarily clinical pattern recognition, this may be acceptable. For migraine with atypical features, an asynchronous-only model has more limitations.

What Medications Does Thirty Madison Prescribe?

Thirty Madison prescribes FDA-approved medications across its four brands. The formulary is narrow by design, focusing on first-line treatments with strong evidence and favorable safety profiles.

Keeps: Hair Loss Medications

Keeps prescribes two core treatments for androgenetic alopecia. Oral finasteride 1 mg daily is a 5-alpha reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT). In a key 5-year trial (N=1,553), finasteride 1 mg produced visible hair regrowth in 48% of men versus 7% on placebo at 2 years [4]. Topical minoxidil 5% solution or foam is the other option. A 48-week randomized trial (N=393) showed that minoxidil 5% produced significantly greater hair regrowth than 2% or placebo [5].

Keeps also offers combination therapy (finasteride plus minoxidil). The American Academy of Dermatology guidelines recommend both agents as first-line for male-pattern hair loss [6]. However, Keeps does not prescribe oral minoxidil, dutasteride, spironolactone, or compounded formulations, limiting options for patients who do not respond to standard therapy.

Cove: Migraine Medications

Cove prescribes acute and preventive migraine therapies. On the acute side, sumatriptan (25-100 mg oral) and rizatriptan (5-10 mg) are available. Both are triptans with well-established efficacy in randomized trials [7]. The American Headache Society recommends triptans as first-line acute therapy for moderate-to-severe migraine [8].

For prevention, Cove offers topiramate (25-100 mg daily), propranolol (40-160 mg daily), and in some cases, nurtec ODT (rimegepant), a CGRP receptor antagonist approved for both acute treatment and prevention. A phase 3 trial (N=747) showed rimegepant 75 mg every other day reduced monthly migraine days by 4.3 versus 3.5 for placebo (P<0.001) [9].

Cove does not prescribe injectable CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab), which require monitoring and are typically administered in-office or via self-injection. This is a meaningful gap for patients with chronic migraine who have failed oral preventives.

Picnic and Facet

Picnic prescribes antihistamines and nasal corticosteroids for allergies. Facet prescribes topical retinoids, topical antibiotics, and spironolactone for acne. These are generally available OTC or through any primary care provider, so the convenience factor is the primary value proposition for these two brands.

Is Thirty Madison Legit? A Clinical Credibility Assessment

Thirty Madison is a legitimate telehealth company. It is not a pharmacy; it partners with licensed pharmacies to dispense medications. Prescriptions are written by providers who hold active state medical licenses. The company is not listed on the FDA's BeSafeRx list of rogue online pharmacies.

Regulatory Standing

The medications prescribed through Thirty Madison are FDA-approved. Finasteride 1 mg (Propecia) received FDA approval in 1997 for androgenetic alopecia. Sumatriptan has been FDA-approved since 1992. These are not experimental or compounded products. The company does not prescribe controlled substances.

Provider Qualifications

Thirty Madison states its providers are board-certified or board-eligible physicians and nurse practitioners. The platform does not publicly disclose its full provider roster, which makes independent verification of credentials difficult. This is a common limitation across asynchronous telehealth platforms, including Hims, Ro, and others.

What the Evidence Does Not Support

No published peer-reviewed study has evaluated Thirty Madison's clinical outcomes specifically. There are no platform-specific data on prescription appropriateness rates, adverse event reporting, or patient outcomes. The medications themselves have strong evidence; the platform's prescribing quality is unmeasured by external researchers. This distinction matters. A 2021 study in JAMA Internal Medicine found that D2C telehealth platforms for hair loss prescribed finasteride in 94% of consultations, raising questions about whether adequate screening for contraindications occurs [10].

How Much Does Thirty Madison Cost?

Pricing varies by brand and medication. Thirty Madison does not accept insurance for its consultation fees, though some patients may be able to submit pharmacy receipts to their insurer for partial reimbursement.

Keeps Pricing

Finasteride through Keeps costs approximately $20-$25 per month on a quarterly subscription. Minoxidil runs $10-$15 per month. Combination plans (finasteride plus minoxidil plus a ketoconazole shampoo) range from $30-$45 per month. For comparison, generic finasteride 1 mg at a retail pharmacy with a GoodRx coupon costs roughly $8-$15 per month, making Keeps modestly more expensive but inclusive of provider consultation and shipping.

Cove Pricing

Cove charges $30-$85 per month depending on the medication. Generic sumatriptan is on the lower end; rimegepant (Nurtec ODT) is at the higher end and may cost more without separate insurance coverage given its brand-only status. A 2023 analysis found the average wholesale price of rimegepant was approximately $93.71 per tablet [11], making any D2C pricing below that potentially subsidized or reflecting negotiated rates.

Hidden Costs to Consider

The quarterly auto-ship model means patients are billed automatically. Cancellation requires contacting customer service, and some consumer reviews report difficulty pausing or canceling subscriptions. The initial consultation fee is included in the first shipment price but may be charged separately if no prescription is issued. Patients who need medication adjustments may incur additional consultation fees.

Thirty Madison vs. Alternatives

Thirty Madison competes with Hims/Hers, Ro, Lemonaid Health, and traditional in-person care. Each has distinct strengths.

Versus Hims and Hers

Hims covers a broader formulary including oral minoxidil, topical finasteride/minoxidil combinations, and compounded products. A 2020 cross-sectional study found that D2C hair loss platforms varied significantly in the treatments offered and clinical information provided [12]. Hims offers synchronous video visits for some conditions, while Thirty Madison relies primarily on asynchronous intake. Pricing is comparable, though Hims frequently runs promotional discounts that undercut Keeps on the first shipment.

Versus Ro (Roman)

Ro offers a broader clinical scope, including weight management with GLP-1 receptor agonists, testosterone replacement therapy, and mental health services. For hair loss specifically, Roman and Keeps prescribe nearly identical formularies at similar price points. Ro's advantage is the ability to address comorbid conditions through a single platform.

Versus In-Person Dermatology or Neurology

An in-person visit provides a physical examination, broader diagnostic capability, and access to the full pharmacopeia including injectable CGRP antibodies, dutasteride, or platelet-rich plasma for hair loss. The tradeoff is access. A dermatology appointment may take over a month to schedule. For patients with straightforward androgenetic alopecia or episodic migraine who meet standard prescribing criteria, asynchronous platforms like Thirty Madison can deliver appropriate first-line treatment faster.

The American Academy of Dermatology's 2020 position statement on teledermatology supports asynchronous store-and-forward models for appropriate clinical scenarios, noting diagnostic concordance rates above 80% for common dermatologic conditions [13].

Limitations and Risks of the Thirty Madison Model

Narrow Formulary

The most significant clinical limitation is formulary breadth. Patients who fail first-line therapy (e.g., finasteride non-responders, triptan non-responders) have limited escalation options within the platform. A 2019 meta-analysis found that approximately 30-40% of migraine patients do not respond adequately to triptans [14]. These patients need access to CGRP-targeted therapies, which Cove offers only in oral form (rimegepant) and not as injectables.

No Lab Monitoring

Thirty Madison does not order or require laboratory testing. For finasteride, the Endocrine Society guidelines do not mandate routine lab monitoring for 1 mg dosing in otherwise healthy men [15]. But for topiramate, monitoring serum bicarbonate is recommended due to the risk of metabolic acidosis, and for propranolol, baseline heart rate and blood pressure should be documented. The asynchronous model relies on patient self-reporting of these values.

Continuity of Care

Patients may not see the same provider for follow-up consultations. This lack of continuity can affect the quality of longitudinal care, particularly for chronic conditions like migraine where treatment response evolves over months. A 2021 systematic review in BMJ Open found that continuity of care in primary settings was associated with lower mortality rates [16].

Who Should (and Shouldn't) Use Thirty Madison

Thirty Madison works best for men aged 18-45 with early-stage androgenetic alopecia (Norwood II-IV) who want convenient access to finasteride and minoxidil. It also suits patients with episodic migraine (fewer than 15 days per month) who have not previously tried triptans or oral preventives.

Patients who should seek in-person care instead: women with hair loss (requires hormonal workup), patients with chronic daily migraine, anyone with cardiovascular disease considering triptans, and patients who have failed two or more medication classes for their condition.

For finasteride specifically, men should be aware of the sexual side effect profile. A pooled analysis of clinical trials found that 3.8% of finasteride 1 mg users reported sexual adverse effects versus 2.1% on placebo, with the majority resolving upon discontinuation [17].